Chemotherapy less likely to benefit older patients with breast cancer
the ONA take:
Examining data from Surveillance, Epidemiology and End Results (SEER) database, researchers from The University of Texas Health Science Center at Houston (UTHealth) found that chemotherapy does not improve survival for older women with breast cancer.
SEER database provided information on 14,440 women with stage I to IIIA hormone receptor-negative breast cancer and 26,893 men and women with stage III colon cancer. All diagnoses were made between 1992 and 2009, and all patients were older than 65 years.
Risk of death from all causes decreased by age among the women who had breast cancer (30% for women ages 65 to 69 years; 26% for ages 70 to 74 years; 24% for ages 75 to 79). The risk of mortality was not significantly reduced for women older than 80 years.
However, this trend was not seen among men and women with colon cancer. Chemotherapy remained effective for these patients until age 89 years.
The investigators noted that previous research showed that chemotherapy is inefficient in patients older than 70 years with breast cancer, but the sample sizes were small. The larger sample size used in this study provides strong evidence to support this finding.
Chemotherapy does not improve survival for older women with breast cancer.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|